CN113616765A - Externally-applied and orally-taken skin bacteriostatic liquid - Google Patents
Externally-applied and orally-taken skin bacteriostatic liquid Download PDFInfo
- Publication number
- CN113616765A CN113616765A CN202110850174.7A CN202110850174A CN113616765A CN 113616765 A CN113616765 A CN 113616765A CN 202110850174 A CN202110850174 A CN 202110850174A CN 113616765 A CN113616765 A CN 113616765A
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- artemisiae argyi
- stem
- red
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
The invention relates to a skin antibacterial liquid capable of being externally applied and orally taken, which is characterized by comprising dandelion, bloody lotus, dendrobium candidum, redbud, sticktight, red bawu, white loquat-like substances, radix boehmeriae, rhynohophylla, safflower, common bluebeard herb, ginger, folium artemisiae argyi, pseudo-ginseng, honeysuckle stem, common loquat leaf, Chinese photinia leaf, kadsura pepper stem, pubescent holly root and red rock bean. The invention has the beneficial effects that: a topical and oral skin antibacterial liquid for regulating female menstruation, and treating rheumatism, traumatic injury, and endocrine disturbance.
Description
Technical Field
The invention relates to the technical field of antibacterial liquid, and particularly relates to skin antibacterial liquid capable of being externally applied and orally taken.
Background
With the development of socioeconomic, people pay more and more attention to physical health, for example, female symptoms such as irregular menstruation, eczema, internal rheumatism, traumatic injury, endocrine disorder and the like are common and common diseases in home health care, and many doctors and medical enterprises strive to innovate local treatment medicines with safety and remarkable curative effect on the treatment of the inflammation.
At present, although there are many medicines and preparations with various names, all of them have the limitation of not ideal curative effect or single function. Therefore, clinically, the antibacterial liquid which is nontoxic and non-irritant to human urogenital skin, mucous membrane, infant skin and mucous membrane, does not contain chemical additives, has a broad-spectrum anti-pathogenic microorganism, a strong anti-inflammatory effect, a wide application range and an obvious curative effect is urgently needed to be developed.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a skin antibacterial liquid which can be externally applied and orally taken for adjusting female menstruation and treating symptoms such as rheumatism, internal rheumatism, traumatic injury, endocrine disorder and the like aiming at the defects of the prior art.
In order to achieve the purpose, the invention provides the following technical scheme: a topical and oral skin antibacterial liquid is prepared from herba Taraxaci, herba Saussureae Involueratae, herba Dendrobii, herba Cephalotaxi, herba Bidentis Bipinnatae, radix Aconiti Kusnezoffii, BAIBAODAO, radix Achyranthis bidentatae, ramulus Uncariae cum uncis, flos Carthami, herba Caryopteridis Incanae, rhizoma Zingiberis recens, folium Artemisiae Argyi, radix Notoginseng, caulis Lonicerae, SHAPAIQI, folium Photiniae, caulis Alangii, radix Ilicis Pubescentis, and HONGYANDOU.
In the technical scheme, the curative effects of the components are as follows: the dandelion has good curative effect on hypertension; the blood lotus, the pubescent holly root and the red rock bean have the functions of cooling and reducing acne; the Dendrobium candidum has effects of tonifying internal organs, resisting aging, reducing high blood pressure, high blood sugar and high blood sugar, and inhibiting tumor; the redhead cedar has the functions of resisting rheumatism and also has curative effect on female irregular menstruation, and the safflower is also used for regulating female irregular menstruation; herba Bidentis Bipinnatae has effects of clearing heat, detoxicating, removing blood stasis and promoting blood circulation, and can be used for treating upper respiratory infection, laryngopharynx swelling and pain, acute appendicitis, acute icterohepatitis, gastroenteritis, rheumatic arthralgia, malaria, skin sore and furuncle, venomous snake bite, and traumatic injury with swelling and pain; radix Aconiti Brachypodi and ramulus Uncariae cum uncis for treating rheumatism and internal rheumatism; the white loquat-like prop has the functions of detumescence and antiphlogosis; radix Achyranthis bidentatae can be used for treating wind-cold; herba Caryopteridis Incanae for treating common cold; rhizoma Zingiberis recens and folium Artemisiae Argyi can be used for soaking foot; notoginseng radix and caulis Lonicerae have effects of removing blood stasis, stopping bleeding, promoting blood circulation, and relieving pain, and can be used for treating hemorrhage, traumatic injury, and swelling and pain due to blood stasis; the folium Photiniae and caulis Piperis Futokadsurae can prevent hand and foot from numbness.
The externally applied and orally taken skin bacteriostatic liquid can be further set as follows: 8-12 g of dandelion, 13-17 g of bloody lotus root, 13-17 g of dendrobium candidum, 6-10 g of redhead cedar, 8-12 g of sticktight, 13-17 g of blackend anemone rhizome, 4-8 g of loquat-like substances, 8-12 g of radix boehmeriae, 13-17 g of rhynohophylla, 4-8 g of safflower, 8-12 g of common bluebeard herb, 6-10 g of ginger, 8-12 g of folium artemisiae argyi, 4-8 g of pseudo-ginseng, 10-14 g of honeysuckle stem, 8-12 g of alpinia japonica, 8-12 g of south leaf of Photinia, 6-10 g of kadsura pepper stem, 8-12 g of pubescent holly root and 6-10 g of red rock bean.
The externally applied and orally taken skin bacteriostatic liquid can be further set as follows: 10g of dandelion, 15g of bloody lotus, 15g of dendrobium candidum, 8g of redhead cedar, 10g of sticktight, 15g of red crow-foot, 6g of white loquat-like channel, 10g of radix boehmeriae, 15g of rhynohophylla, 6g of safflower, 10g of common bluebeard herb, 8g of ginger, 10g of folium artemisiae argyi, 6g of pseudo-ginseng, 12g of honeysuckle stem, 10g of alpinia japonica, 10g of folium photiniae, 8g of kadsura pepper stem, 10g of pubescent holly root and 8g of red rock bean.
The invention has the beneficial effects that: the bacteriostatic solution composed of the components can be orally taken and externally applied, and the curative effect is better compared with the prior art; the bacteriostatic liquid has the following functions: the bacteriostatic liquid has good curative effect on female irregular menstruation, can help female menstrual flow and menstrual period to recover to normal, is beneficial to eye pouch detumescence, old scar recovery, wrinkle growth reduction, weight reduction, treatment of internal rheumatism and the like, can be used by people with hypertension and hyperglycemia, and is also beneficial to improving sleep quality.
The present invention will be described in further detail with reference to examples.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A topical and oral skin antibacterial liquid comprises herba Taraxaci, herba Saussureae Involueratae, herba Dendrobii, herba Cephalotaxi, herba Bidentis Bipinnatae, radix Aconiti Coreani, radix Cynanchi Atrati, radix Achyranthis bidentatae, ramulus Uncariae cum uncis, flos Carthami, herba Caryopteridis Incanae, rhizoma Zingiberis recens, folium Artemisiae Argyi, radix Notoginseng, caulis Lonicerae, SHAPAIQI, folium Photiniae, caulis Piperis Futokadsurae, radix Ilicis Pubescentis, and HONGYANDOU.
8-12 g of dandelion, 13-17 g of bloody lotus root, 13-17 g of dendrobium candidum, 6-10 g of redhead cedar, 8-12 g of sticktight, 13-17 g of blackend anemone rhizome, 4-8 g of loquat-like substances, 8-12 g of radix boehmeriae, 13-17 g of rhynohophylla, 4-8 g of safflower, 8-12 g of common bluebeard herb, 6-10 g of ginger, 8-12 g of folium artemisiae argyi, 4-8 g of pseudo-ginseng, 10-14 g of honeysuckle stem, 8-12 g of loquat leaf, 8-12 g of south China leaf, 6-10 g of kadsura pepper stem, 8-12 g of pubescent holly root and 6-10 g of red rock bean.
The first embodiment is as follows: a skin antibacterial liquid for external application and oral administration comprises herba Taraxaci 10g, herba Saussureae Involueratae 15g, herba Dendrobii 15g, herba Cephalotaxi 8g, herba Bidentis Bipinnatae 10g, radix Aconiti Kusnezoffii 15g, folium Eriobotryae 6g, radix Achyranthis bidentatae 10g, ramulus Uncariae cum uncis 15g, flos Carthami 6g, herba Caryopteridis Incanae 10g, rhizoma Zingiberis recens 8g, folium Artemisiae Argyi 10g, radix Notoginseng 6g, caulis Lonicerae 12g, SHAPAIQI 10g, folium Photiniae 10g, caulis Illicii, radix Ilicis Pubescentis 10g, and HONGYANDOU 8 g.
The bacteriostatic solution composed of the components can be orally taken and externally applied, and the curative effect is better compared with the prior art; the bacteriostatic liquid has the following functions: the bacteriostatic liquid has good curative effect on female irregular menstruation, can help female menstrual flow and menstrual period to recover to normal, is beneficial to eye pouch detumescence, old scar recovery, wrinkle growth reduction, weight reduction, treatment of internal rheumatism and the like, can be used by people with hypertension and hyperglycemia, and is also beneficial to improving sleep quality.
Claims (3)
1. A skin bacteriostatic liquid capable of being externally applied and orally taken is characterized in that: comprises herba Taraxaci, herba Saussureae Involueratae, herba Dendrobii, herba Cephalotaxi, herba Bidentis Bipinnatae, radix Aconiti Coreani, BAIBUO, BAIBAIDAO, Achyranthis radix, ramulus Uncariae cum uncis, Carthami flos, herba Caryopteridis Incanae, rhizoma Zingiberis recens, folium Artemisiae Argyi, Notoginseng radix, caulis Lonicerae, SHANPAIQI, folium Photiniae, caulis Illicii Lanceolati, radix Ilicis Pubescentis, and HONGYANDOU.
2. The topical and oral skin bacteriostatic solution according to claim 1, wherein: 8-12 g of dandelion, 13-17 g of bloody lotus root, 13-17 g of dendrobium candidum, 6-10 g of redhead cedar, 8-12 g of sticktight, 13-17 g of blackend anemone rhizome, 4-8 g of loquat-like substances, 8-12 g of radix boehmeriae, 13-17 g of rhynohophylla, 4-8 g of safflower, 8-12 g of common bluebeard herb, 6-10 g of ginger, 8-12 g of folium artemisiae argyi, 4-8 g of pseudo-ginseng, 10-14 g of honeysuckle stem, 8-12 g of alpinia japonica, 8-12 g of south leaf of Photinia, 6-10 g of kadsura pepper stem, 8-12 g of pubescent holly root and 6-10 g of red rock bean.
3. The topical and oral skin bacteriostatic liquid according to claim 2, wherein: 10g of dandelion, 15g of bloody lotus, 15g of dendrobium candidum, 8g of redhead cedar, 10g of sticktight, 15g of red crow-foot, 6g of white loquat-like channel, 10g of radix boehmeriae, 15g of rhynohophylla, 6g of safflower, 10g of common bluebeard herb, 8g of ginger, 10g of folium artemisiae argyi, 6g of pseudo-ginseng, 12g of honeysuckle stem, 10g of alpinia japonica, 10g of folium photiniae, 8g of kadsura pepper stem, 10g of pubescent holly root and 8g of red rock bean.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110850174.7A CN113616765A (en) | 2021-07-27 | 2021-07-27 | Externally-applied and orally-taken skin bacteriostatic liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110850174.7A CN113616765A (en) | 2021-07-27 | 2021-07-27 | Externally-applied and orally-taken skin bacteriostatic liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113616765A true CN113616765A (en) | 2021-11-09 |
Family
ID=78381100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110850174.7A Pending CN113616765A (en) | 2021-07-27 | 2021-07-27 | Externally-applied and orally-taken skin bacteriostatic liquid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113616765A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118319830A (en) * | 2024-04-22 | 2024-07-12 | 广州秉科生物科技有限公司 | Skin tightening and anti-wrinkle essence and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111150828A (en) * | 2020-03-09 | 2020-05-15 | 梁大伟 | Pure Chinese herbal medicine medicated bath formula for health care and health preservation |
CN111686152A (en) * | 2020-07-13 | 2020-09-22 | 北京安德普泰医疗科技有限公司 | External composition and gel for treating lymphedema and preparation method thereof |
CN113318094A (en) * | 2021-05-08 | 2021-08-31 | 广州贝昊医疗科技有限公司 | Silicone gel patch containing plant herbal components and manufacturing method thereof |
-
2021
- 2021-07-27 CN CN202110850174.7A patent/CN113616765A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111150828A (en) * | 2020-03-09 | 2020-05-15 | 梁大伟 | Pure Chinese herbal medicine medicated bath formula for health care and health preservation |
CN111686152A (en) * | 2020-07-13 | 2020-09-22 | 北京安德普泰医疗科技有限公司 | External composition and gel for treating lymphedema and preparation method thereof |
CN113318094A (en) * | 2021-05-08 | 2021-08-31 | 广州贝昊医疗科技有限公司 | Silicone gel patch containing plant herbal components and manufacturing method thereof |
Non-Patent Citations (1)
Title |
---|
姜华: "中药溻渍法治疗糖尿病足局部溃疡疗效观察", 《现代中西医结合杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118319830A (en) * | 2024-04-22 | 2024-07-12 | 广州秉科生物科技有限公司 | Skin tightening and anti-wrinkle essence and preparation method thereof |
CN118319830B (en) * | 2024-04-22 | 2025-01-28 | 广州博科化妆品有限公司 | Skin tightening and anti-wrinkle essence and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3466447B1 (en) | Pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
CN105030621A (en) | Moisturizing and acne removing toner and preparing method thereof | |
CN113616765A (en) | Externally-applied and orally-taken skin bacteriostatic liquid | |
CN104474391A (en) | Medicine for treating skin itch | |
CN101167991A (en) | Burn and scald treating ointment | |
CN109549958B (en) | Composition for treating hormone-dependent dermatitis and preparation method thereof | |
CN103638316B (en) | Traditional Chinese medicine preparation for treating dermatitis | |
CN1318052C (en) | Medicine compositions for treating acne, and its prepn. method | |
CN106822321B (en) | Application of Curcuma water of traumatology in preparing medicine for treating keratosis pilaris | |
CN1261140C (en) | Medicine for treating burns and scalds | |
CN104491825B (en) | A kind of Chinese medicine ointment for the treatment of oral ulcer | |
CN1385193A (en) | Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration | |
CN107982387A (en) | A kind of Chinese medicine composition for treating scald and preparation method thereof | |
CN102772485A (en) | External multi-functional ointment for clearing away heat and toxic materials | |
CN106511676A (en) | Traditional Chinese medicine composition for treating bedsore in clinical nursing | |
CN105250568A (en) | Medicinal composition for treating scalds and burns and preparation method thereof | |
CN105031254A (en) | Ointment used for treating dermatitis and preparation method thereof | |
CN104784637A (en) | Traditional Chinese medicine composition for treating diabetic peripheral neuropathy during foot bath | |
CN115154550B (en) | A kind of external Chinese medicinal composition for treating ulcerative lymph node tuberculosis | |
CN110585379A (en) | External application medicine for treating dermatitis | |
CN109172732A (en) | A kind of Chinese medicine composition and the preparation method and application thereof of anti-HPV | |
CN108420952A (en) | Eliminating inflammation and expelling toxin diuresis soup | |
CN106729248A (en) | It is a kind of to treat Chinese medicine composition of pudendal pruritus and preparation method thereof | |
CN118320000A (en) | Traditional Chinese medicine composition with detoxifying and blood cooling effects, detoxifying and blood cooling mixture as well as preparation method and application thereof | |
CN105250433A (en) | Externally applied traditional Chinese medicine ointment for treating hemorrhoids and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211109 |
|
RJ01 | Rejection of invention patent application after publication |